2
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Neoplasms
15
Papillomavirus Infections
9
Uterine Cervical Neoplasms
7
Pancreatic Neoplasms
6
Breast Neoplasms
6
Ovarian Neoplasms
5
Prostatic Neoplasms
4
Neuroendocrine Tumors
4
Neoplasm Metastasis
4
Myasthenia Gravis
3
Multiple Myeloma
3
Melanoma
3
Lymphoma
3
Lung Neoplasms
3
Autoimmune Diseases
3
Thyroid Diseases
2
Pancreatic Cyst
2
Neuroblastoma
2
Mesothelioma, Malignant
2
Lymphoma, Non-Hodgkin
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Hairy Cell
2
Leukemia
2
Hematologic Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
COVID-19
2
Brain Neoplasms
2
Abortion, Spontaneous
2
Interventions
fludarabine
4
Cyclophosphamide
4
Specimen Handling
2
Nivolumab
2
Natalizumab
2
Interferon beta-1b
2
Fingolimod Hydrochloride
2
Blood Specimen Collection
2
teriflunomide
1
nabiximols
1
gadobutrol
1
gadobenic acid
1
cabozantinib
1
Surveys and Questionnaires
1
Respiratory Therapy
1
Registries
1
Platinum Compounds
1
Platelet Transfusion
1
Plasma Exchange
1
Phlebotomy
1
OM 89
1
Mn-PyC3A
1
Medical Marijuana
1
Magnetic Resonance Spectroscopy
1
Magnetic Resonance Imaging
1
Ipilimumab
1
Interferon beta-1a
1
Injections
1
Gadolinium DTPA
1
Fish Oils
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Multiple Sclerosis
×
Data Collection
×
Clear all
NCT06443333
2024-06-05
NIDBase
Xuanwu Hospital, Beijing
Unknown
7,000 enrolled